Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1CAM2029 (octreotide subcutaneous depot) _prefilled syringe_prefilled syringe
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
2CAM2029 (octreotide subcutaneous depot)_ prefilled PEN
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
3CAM2029 (octreotide subcutaneous depot)_ prefilled syringe
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
4CAM2029 (octreotide subcutaneous depot)_pre-filled PEN
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
5CAM2029 (octreotide subcutaneous depot)_pre-filled syringe
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
6CAM2029 (octreotide subcutaneous depot)_prefilled PEN
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
7CAM2029 (octreotide subcutaneous depot)_prefilled syringe
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
8Combination with somatostatin analogue octreotide
(D02250)		----[1] 77 💬
9Gallium-68-DOTA-N-octreotide
(D02250)		----[1] 84 💬
10Lanreotide autogel and octreotide LAR
(D02250)		[1] Lanreotide[1] Lanreotide acetate 💬 [2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
11Octreotide
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[8] 67, 75, 77, 84, 85, 89, 193, 227 💬
12Octreotide A azione pronta 0,1 MG
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 227 💬
13Octreotide acetate
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 77, 227 💬
14Octreotide acetate 30 MG suspension
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
15Octreotide acetate and cabergoline/octrotide and somavert
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
16Octreotide acetate microspheres FOR injection injection
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
17Octreotide acetate prolonged release, 30 MG
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
18Octreotide acetato
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 77, 227 💬
19Octreotide capsules
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
20Octreotide fluidcrystal® injection depot
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
21Octreotide hydrochloride
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
22Octreotide implant
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
23Octreotide LAR
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[3] 67, 77, 227 💬
24Octreotide LAR 30 MG injection
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
25Octreotide LAR 30MG
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
26Octreotide-LAR
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 67, 77 💬
27Octreotide-LAR or lanreotide
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
28PRE-treatment with octreotide
(D02250)		----[1] 77 💬
29Sandostatin LAR ® (octreotide acetate LAR) 30 MG
(D02250)		[1] Octreotide[4] Octreotide ,
Octreotide acetate (D02250),
Octreotide pamoate ,
Octreotide acetate 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬